CVKD

Cadrenal Therapeutics, Inc. Common Stock$5.26-0.44 (-7.72%)

Prev Close$5.70·MCap$18.7M·P/E—·Vol45.1K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$709.8K

◆

Net Activity

Net Seller

$709.8K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Cadrenal Therapeutics, Inc. Common Stock (CVKD) has been exclusively selling, with 0 insider purchases totaling $0.00 and 13 insider sales totaling $709.8K. The most recent insider transaction was by Szot Matthew K (Chief Financial Officer), who sold $69.2K worth of shares on Dec 29, 2025. Cadrenal Therapeutics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $18.7M.

CVKD Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value
Dec 29, 2025	Szot Matthew K	Chief Financial Officer	Sell	9,933	$6.97	$69.2K
Oct 24, 2025	Pham Quang X	CEO and Chairman	Sell	2,444	$14.01	$34.2K
Oct 24, 2025	Szot Matthew K	Chief Financial Officer	Sell	3,600	$13.99	$50.4K
Oct 9, 2025	Pham Quang X	CEO and Chairman	Sell	3,600	$14.09	$50.7K
Oct 9, 2025	Szot Matthew K	Chief Financial Officer	Sell	3,493	$14.03	$49.0K
Oct 6, 2025	Szot Matthew K	Chief Financial Officer	Sell	107	$13.99	$1.5K
Oct 2, 2025	Pham Quang X	CEO and Chairman	Sell	500	$14.13	$7.1K
Sep 29, 2025	Pham Quang X	CEO and Chairman	Sell	1,300	$14.01	$18.2K
Sep 29, 2025	Szot Matthew K	Chief Financial Officer	Sell	1,800	$13.99	$25.2K
Sep 24, 2025	Pham Quang X	CEO and Chairman	Sell	9,371	$14.06	$131.8K
Sep 24, 2025	Szot Matthew K	Chief Financial Officer	Sell	12,400	$14.05	$174.2K0.5% OS
Aug 27, 2025	Pham Quang X	CEO and Chairman	Sell	5,029	$13.99	$70.4K
Aug 27, 2025	Szot Matthew K	Chief Financial Officer	Sell	2,000	$14.00	$28.0K
Oct 4, 2023	MURPHY JOHN RAYMOND	Director	Buy	20,000	$0.70	$14.0K0.9% OS
Sep 5, 2023	Pham Quang X	CEO and Chairman	Buy	40,000	$0.90	$36.2K1.7% OS
Sep 1, 2023	Pham Quang X	CEO and Chairman	Buy	70,000	$0.91	$63.9K3.0% OS
Mar 21, 2023	MURPHY JOHN RAYMOND	Director	Buy	10,000	$1.39	$13.9K
Mar 16, 2023	MURPHY JOHN RAYMOND	Director	Buy	20,000	$1.67	$33.4K0.9% OS

CVKD Insider Buying Activity

The following table shows recent insider purchases of Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Oct 4, 2023	MURPHY JOHN RAYMOND	Director	Buy	20,000	$0.70	$14.0K0.9% OS
Sep 5, 2023	Pham Quang X	CEO and Chairman	Buy	40,000	$0.90	$36.2K1.7% OS
Sep 1, 2023	Pham Quang X	CEO and Chairman	Buy	70,000	$0.91	$63.9K3.0% OS
Mar 21, 2023	MURPHY JOHN RAYMOND	Director	Buy	10,000	$1.39	$13.9K
Mar 16, 2023	MURPHY JOHN RAYMOND	Director	Buy	20,000	$1.67	$33.4K0.9% OS

CVKD Insider Selling Activity

The following table shows recent insider sales of Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Dec 29, 2025	Szot Matthew K	Chief Financial Officer	Sell	9,933	$6.97	$69.2K
Oct 24, 2025	Pham Quang X	CEO and Chairman	Sell	2,444	$14.01	$34.2K
Oct 24, 2025	Szot Matthew K	Chief Financial Officer	Sell	3,600	$13.99	$50.4K
Oct 9, 2025	Pham Quang X	CEO and Chairman	Sell	3,600	$14.09	$50.7K
Oct 9, 2025	Szot Matthew K	Chief Financial Officer	Sell	3,493	$14.03	$49.0K
Oct 6, 2025	Szot Matthew K	Chief Financial Officer	Sell	107	$13.99	$1.5K
Oct 2, 2025	Pham Quang X	CEO and Chairman	Sell	500	$14.13	$7.1K
Sep 29, 2025	Pham Quang X	CEO and Chairman	Sell	1,300	$14.01	$18.2K
Sep 29, 2025	Szot Matthew K	Chief Financial Officer	Sell	1,800	$13.99	$25.2K
Sep 24, 2025	Pham Quang X	CEO and Chairman	Sell	9,371	$14.06	$131.8K
Sep 24, 2025	Szot Matthew K	Chief Financial Officer	Sell	12,400	$14.05	$174.2K0.5% OS
Aug 27, 2025	Pham Quang X	CEO and Chairman	Sell	5,029	$13.99	$70.4K
Aug 27, 2025	Szot Matthew K	Chief Financial Officer	Sell	2,000	$14.00	$28.0K